Đang chuẩn bị liên kết để tải về tài liệu:
Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

The optimal treatment regimen or protocol for managing a persistent patent ductus arteriosus (PDA) in extremely low birth weight (ELBW) infants has not been well established. This study was aimed at evaluating the failure rate of a cyclooxygenase (COX) inhibitor (COI) for PDA closure and to determine the incidence of a PDA requiring ligation in ELBW infants. | Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants

TÀI LIỆU LIÊN QUAN

Heart failure - Trương Thanh Hương, PhD

Ebook Drug and device selection in heart failure: Part 1

Ebook Failure analysis case studies II: Part 2

Ebook Drug and device selection in heart failure: Part 2

Ebook The 4 stages of heart failure: Part 2

Ebook The 4 stages of heart failure: Part 1

Social sciences with success and failure of nations

Reduction of internal failure costs of soap production company and refined oil

Effect of tuberculosis co infection on virological failure in HIV patients on first line of highly active antiretroviral therapy

Knowledge and practice about self-care among patients with chronic heart failure at Hop Luc general hospital, Thanh Hoa in 2020
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.